aflibercept | iPharmaCenter

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

Novartis Beovu demonstrated non-inferiority vs. aflibercept in the PEP and superiority in SEP

ipharmaservices

Sep 14, 2020

Novartis Beovu demonstrated non-inferiority vs. aflibercept in the PEP and superiority in SEP

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page